HLA-DQA1 and Crohn disease: Two previous studies, by Wilson et al. and Sazonovs et al., identified an association between the genetic variant HLA-DQA1*05 and the formation of anti-drug antibodies, against both infliximab and adalimumab, in patients with Crohn's disease (CD) (25, 26).